Krueger Christopher W's Form 4/A amendment
AmendedVentyx Biosciences, Inc. (VTYX) · filed Aug 4, 2023
- Accession no.
- 0001209191-23-044662
- Filed
- Aug 4, 2023
- Trade date
- Jul 3, 2023
- Filing delay
- 32 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 5, 2023
This filing lists 2 derivative transactions. It carries over 8 transactions from the original filing that it did not restate. Open-market sales total $588.3K. It was filed 32 days after the trade.
This amendment restates part of 0001209191-23-041353 (filed Jul 5, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krueger Christopher WCIK 0001394208 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | Common Stock | MOption exerciseDisposed | −1,089 | $0.00 | $0 | 149,371 | Direct | |
| Jul 3, 2023 | Common Stock | MOption exerciseDisposed | −13,911 | $0.00 | $0 | 0 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-23-041353 (filed Jul 5, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | Common Stock | MOption exerciseAcquired | +1,089 | $8.04 | +$8,755.56 | 277,637 | Direct | |
| Jul 3, 2023 | Common Stock | MOption exerciseAcquired | +13,911 | $0.20 | +$2,782.2 | 291,548 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −403 | $33.57F2 | −$13,527.54 | 291,145 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −214 | $34.72F3 | −$7,430.51 | 290,931 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −40 | $35.50F4 | −$1,419.88 | 290,891 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −1,960 | $38.05F5 | −$74,573.49 | 288,931 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −2,150 | $38.79F6 | −$83,399.15 | 286,781 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −10,233 | $39.87F7 | −$407,992.78 | 276,548 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
Represents the weighted average share price of an aggregate total of 403 shares sold in the price range of $33.23 to $34.1212. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 214 shares sold in the price range of $34.2599 to $35.2093. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average share price of an aggregate total of 40 shares sold in the price range of $35.2747 to $35.7192. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average share price of an aggregate total of 1,960 shares sold in the price range of $37.2788 to $38.2782. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average share price of an aggregate total of 2,150 shares sold in the price range of $38.2802 to $39.28. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average share price of an aggregate total of 10,233 shares sold in the price range of $39.2812 to $40.05. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed to correct the transaction date reported in the Form 4 filed July 5, 2023.
- F2
Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the options shall vest on the one year anniversary of the Vesting Commencement date, and, thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean September 17, 2021.
- F3
Option granted under the 2019 Plan. Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2019 Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 1, 2020.